BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With RNA technologies receiving the Nobel Prize two years runn
 ing\, we are witnessing the mRNA industry make great strides as optimized
  analytics\, critical quality control methodology and robust assay develo
 pment lead to efficient approvals and commercialization. However\, develo
 ping\, validating and transferring methods to demonstrate drug substance 
 and product CQAs remains no easy feat\, as knowledge gaps persist in phas
 e appropriate potency assays\, analyzing LNP payloads and novel cell-targ
 eted delivery systems\, controlling dsRNA\, and navigating the global mRN
 A therapeutics and vaccine regulatory seas for approval in unmet patient 
 need.\n\nFor the very first time\, the 4th mRNA Analytical Development an
 d Quality Control Summit will unite the tightly knit assay development\, 
 analytical and quality control communities\, providing these technical te
 ams with the means to secure regulatory submissions for 2025 and beyond.\
 n\nURLs:Tickets: https://go.evvnt.com/2713888-2?pid=185Brochure: https://
 go.evvnt.com/2713888-3?pid=185\n\nTime: 8:00 AM - 4:30 PM\n\nSpeakers: Zh
 anyong (James) Shu\, Vice President\, Analytical Science\, Abogen Bioscie
 nces\, Srujan Gandham\, Associate Director\, Analytical Development\, Aer
 a Therapeutics\, Zack Zhang\, Director\, Analytical Development\, Beam Th
 erapeutics\, Jan Michel\, Falcke Director Global AS and T\, BioNTech\, Em
 net Yitbarek\, Scientist\, FDA\, Juan Bian\, Principal Scientist\, Genent
 ech\, Diana Posadas\, Director\, Strategic Research\, Greenlight Bioscien
 ces\, Rameh Hafezi\, Associate Director\, Analytical Technologies\, Grits
 tone Bio\, Ajit Magadum\, Assistant Professor\, Lewis Katz School of Medi
 cine at Temple University\, Glenn Milton\, Senior Scientist\, Analytical 
 Development\, Moderna\, Mehdi Shirzadeh\, Senior Scientist\, Analytical D
 evelopment\, Moderna\, Joyce Zhao\, Director\, Head of Analytical Science
 \, Myeloid Therapeutics\, Chris Broomell\, Head of Analytical Development
 \, Omega Therapeutics\, Thareendra De Zoysa\, Scientist\, Orna Therapeuti
 cs\, Erin Wierzbicki\, Senior Manager\, GCMC Regulatory Affairs\, mRNA Va
 ccines\, Pfizer\, Kelly Sackett\, Senior Principal Scientist\, Pfizer\, R
 ebecca Malott\, Senior Manager\, Analytical Providence\, Therapeutics\, E
 lisha Fielding\, Director\, Sail Biomedicines\, Dinesh Manvar\, Associate
  Director\, Analytical Development\, Sail Biomedicines\, Lusheng Fan\, Se
 nior Scientist\, Sanofi\, Anna Dudkina\, Director\, Analytical Developmen
 t\, Tessera Therapeutics\, Jonathan Maurer\, Post-Doctoral Researcher\, U
 niversity of Geneva and Sanofi\, Jason Zhang\, Co-Founder and Chief Execu
 tive Officer\, Zipcode Bio\n
DTEND:20250227T163000
DTSTAMP:20260512T232301Z
DTSTART:20250225T080000
LOCATION:Revere Hotel Boston Common\, 200\, Stuart Street\, Boston\, Massa
 chusetts\, 02116\,
SEQUENCE:0
SUMMARY:With RNA technologies receiving the Nobel Prize two years running\
 , we are witnessing the mRNA industry make great strides as optimized ana
 lytics\, c...
UID:59ef470e-404a-4a91-9867-400c9d1683a7
END:VEVENT
END:VCALENDAR